Continuing Coverage:

Paclitaxel In PAD

In December 2018, a study-level meta-analysis published in JAHA indicated a link between the use of paclitaxel-delivery devices for peripheral artery disease and increased mortality. Subsequently, regulators, clinical trial investigators, and manufacturers of drug-coated balloons and drug-eluting stents have initiated reviews of patient-level data in order to determine whether a causal link could be established or denied.

Links to key primary source documents and Endovascular Today's ongoing coverage can be found below. This page will be updated as new data and reports emerge.